Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2008
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists
Andrew G Cole, Axel Metzger, Marc-Raleigh Brescia, et al.
Journal of Medicinal Chemistry
|
October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta
Martin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Journal of Medicinal Chemistry
|
February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"
Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
Nature Communications
|
October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
Kevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2008
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists
Andrew G Cole, Axel Metzger, Marc-Raleigh Brescia, et al.
Journal of Medicinal Chemistry
|
October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta
Martin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Journal of Medicinal Chemistry
|
February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"
Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
Nature Communications
|
October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
Kevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Page
of 10